Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w

Incidence of ventricular tachyarrhythmias and clinical outcomes in primary prophylactic ICD patients in relation to type of myocardial infarction
T. Kleemann1, K. Kouraki1, M. Strauß1, O. Mohammad1, A.-R. Wenz1, R. Zahn1
1Medizinische Klinik B, Klinikum der Stadt Ludwigshafen gGmbH, Ludwigshafen am Rhein;

Introduction: According to current guidelines, primary prophylactic ICD implantation is indicated with a class I A recommendation in patients with severely reduced EF < 35% and ischaemic heart disease. However, it is unclear whether there are differences in patient outcomes related to the type of myocardial infarction. Aim of the study was to compare the incidence of ventricular tachyarrhythmias and clinical outcomes in primary prophylactic ICD-patients with ischaemic heart disease in relation to the type of myocardial infarction. Methods: A total of 448 consecutive ICD patients from a prospective single-centre ICD-registry who underwent primary prophylactic ICD implantation due to ischaemic cardiomyopathy between 1996 and 2021were analyzed. Patients with previous anterior wall myocardial infarction (AWMI, n = 293) were compared to those with posterior wall myocardial infarction (PWMI, n = 155). Patients with both AWMI and PWMI were excluded. The median follow-up time was 6 years in both groups. Results: Clinical characteristics of patients with AMWI were younger, more often female, and less often received cardiac synchronization therapy (Table 1).  Patients with previous PWMI more often had ICD therapy during follow-up (Figure 1). This difference was driven by the higher incidence of ventricular tachycardias (Table 1). The all-cause mortality rate was similar between both groups. Conclusion: Primary prophylactic ICD patients with previous PWMI have a 10% higher incidence of ventricular tachycardias after 6-year follow-up than ICD patients with previous AMWI. This might be explained by the proximity of the inferior infarction to the mitral isthmus and should be considered when ablating VTs in patients with PWMI.


 

Table 1. Clinical characteristics and outcomes with relation to the type of myocardial infarction

   

AWMI

(n = 293)
 

PWMI

(n = 155)
 p-value
 Age (years)  62 + 10  66 + 8  < 0.001
 Female  17%  8%  < 0.01
 EF < 30%  82%  74%  0.03
 Diabetes  31%  34%  n.s.
 CRT  22%  30%  0.04
 Renal failure  28% 29%  n.s.
 ACE/ARB/Entresto  98%  97%  n.s.
 Beta blocker  95%  94%  n.s.
 Spironolactone  60%  51%  < 0.01
 ICD therapy during FU  38%  47%  < 0.01
 Electrical storm VF  8%  7%  n.s.
 Electrical storm VT  7%  12%  0.05
 VF shock  19%  17%  n.s.
 VT shock  21%  32%  0.01
 VT ATP  22%  34% 0.007
 5-year all-cause mortality  19%  21%  n.s.


Figure 1



https://dgk.org/kongress_programme/jt2023/aV1110.html